Skip Navigation

2008-09 Diabetes Interdisciplinary Study Program (DISP)

Co-sponsored by the Michigan Comprehensive Diabetes Center (MCDC) and the Michigan Diabetes Research and Training Center (MDRTC)

Funding: up to $100,000

PURPOSE

The Diabetes Interdisciplinary Studies Program (DISP) is jointly sponsored by the Michigan Diabetes Research and Training Center (MDRTC) and the Michigan Comprehensive Diabetes Center (MCDC). Its purpose is to promote interdisciplinary collaboration between TWO members of the University of Michigan faculty from DISTINCT disciplines to focus their combined research strengths on cutting-edge areas in diabetes research. The intent is to foster synergistic collaboration between faculty members to advance scientific inquiry. Grant proposals may be in areas of basic biomedical research, or in clinical, behavioral, epidemiological, health services, or translational research and should address key questions in the pathogenesis, diagnosis, prevention, or control of diabetes, its complications, or related endocrine or metabolic disorders (for example: counter-regulatory proteins, obesity, metabolic syndrome). The goal of the DISP is to enable investigators to generate a sufficient body of preliminary information for a successful application for major research funding from NIH or other national granting agencies.

ELIGIBILITY

A minimum of two Co-Investigators are required as DISP applicants. Individuals who have full-time instructional, research or clinical track faculty positions at the University of Michigan are eligible to apply as Co-Principal Investigators of a DISP proposal. Whereas the intent of this grant is to foster new collaborations on campus, applications for new research initiatives from productive ongoing collaborations will not be excluded from consideration. Each Co-Principal Investigator must provide critical intellectual as well as technical input into projects funded by a DISP grant. Individuals that receive the 2009-10 DISP grant (jointly sponsored by the MDRTC and MCDC) are not eligible to receive a 2009-10 MDRTC Pilot/Feasibility Grant.

APPLICATIONS

Applications must be prepared using the new 2009-10 DISP P/F application. An application form can be obtained by calling Pam Campbell in the MDRTC at 763-5730 or emailing (pamcamp@umich.edu). Proposals should be for one year of support, with requested funding up to $100,000. Funds may not be applied to salary support for the Principal Investigator, travel expenses, or purchase of equipment (i.e., durable items costing over $5000). Funds may be applied for a postdoctoral fellow or research assistant.

Each proposal will receive peer review by a group of recognized experts in the area of the proposal from the United States and abroad. In this initial round of applications, it is anticipated that at least one and up to three projects will be selected for funding effective in December 2009.

Application due date: 5 PM Monday, August 3, 2009

MDRTC DISP AWARD TERMS

Past Awardees

1) Awardees are required to inform the MDRTC in the event that the Pilot/Feasibility Project receives external funding during the project period.

2) A final progress report is due one month after the close of the project period. The one page report will contain a synopsis of scientific progress, a list of resulting collaborations, publications, and grants, and a description of the relationship of the project to Core usage.

3) Awardees will provide updates concerning other support, resulting publications, and research activities for the Center's annual reports and continuation application.

4) Biomedical awardees will attend the Biomedical Winter Symposium (generally held in April each year) and present a poster on their research.

5) Publications resulting from the (MDRTC) funding must acknowledge grant support: NIH DK020572.

Please cite the following in publications resulting from or based on this work:
“This work utilized ______Core(s) of the Michigan Diabetes Research and Training Center funded by NIH DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases.”